Pro-med (Beijing) Technology Co., Ltd. was established in 2013, mainly engaged in the R&D, production and sales of blood coagulation, immune and molecular diagnostic equipment and reagents, and owns enterprises of Jiangsu Aoya, Suzhou Smart Bio and other subsidiaries.Pro-med will always adhere to the concept of “science and technology make the diagnosis better “, follow the professional, honest, efficient and innovative values, take the internationally first micro-fluidic thromboelastogram and accurate diagnosis of maternal and child cardiovascular as the core, and strive to become a first-class international leading brand in the field of in vitro diagnosis (IVD).
The immunofluorescence platform includes 50+ kinds of reagents and three high-performance devices, focusing on detecting cardiovascular disease, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and others.
The colloidal gold platform can cover the detection of more than 20 kinds of markers, such as clinical common inflammation and infection, stomach health, cardiovascular and cerebrovascular, bone health, iron deficiency anemia, pregnancy detection, renal function detection, etc.
Since its establishment, our factory has been developing first world class products with adhering the principle of quality first. Our products have gained excellent reputation in the industry and valuabletrusty among new and old customers..submit now